Topics

An FDA advisory panel is reviewing Aimmune’s peanut allergy therapy. Here’s what’s happening

10:03 EDT 13 Sep 2019 | STAT

STAT's @adamfeuerstein will be watching watching a live feed of today’s FDA advisory panel to discuss a peanut allergy treatment. Follow along for updates.

Original Article: An FDA advisory panel is reviewing Aimmune’s peanut allergy therapy. Here’s what’s happening

NEXT ARTICLE

More From BioPortfolio on "An FDA advisory panel is reviewing Aimmune’s peanut allergy therapy. Here’s what’s happening"

Quick Search

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...